Veradigm Revenue 2010-2022 | MDRX
Veradigm revenue from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Veradigm Annual Revenue (Millions of US $) |
|
|---|---|
| 2022 | $588 |
| 2021 | $577 |
| 2020 | $556 |
| 2019 | $1,633 |
| 2018 | $1,618 |
| 2017 | $1,498 |
| 2016 | $1,386 |
| 2015 | $1,386 |
| 2014 | $1,378 |
| 2013 | $1,373 |
| 2012 | $1,446 |
| 2011 | $1,444 |
| 2010 | $613 |
| 2010 | $705 |
| 2009 | $548 |
| Veradigm Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2022-12-31 | $143 |
| 2022-09-30 | $152 |
| 2022-06-30 | $151 |
| 2022-03-31 | $143 |
| 2021-12-31 | $158 |
| 2021-09-30 | $145 |
| 2021-06-30 | $141 |
| 2021-03-31 | $134 |
| 2020-12-31 | $-560 |
| 2020-09-30 | $366 |
| 2020-06-30 | $369 |
| 2020-03-31 | $381 |
| 2019-12-31 | $312 |
| 2019-09-30 | $444 |
| 2019-06-30 | $444 |
| 2019-03-31 | $432 |
| 2018-12-31 | $310 |
| 2018-09-30 | $432 |
| 2018-06-30 | $441 |
| 2018-03-31 | $434 |
| 2017-12-31 | $209 |
| 2017-09-30 | $449 |
| 2017-06-30 | $426 |
| 2017-03-31 | $413 |
| 2016-12-31 | $262 |
| 2016-09-30 | $392 |
| 2016-06-30 | $387 |
| 2016-03-31 | $346 |
| 2015-12-31 | $346 |
| 2015-09-30 | $354 |
| 2015-06-30 | $352 |
| 2015-03-31 | $335 |
| 2014-12-31 | $341 |
| 2014-09-30 | $345 |
| 2014-06-30 | $351 |
| 2014-03-31 | $340 |
| 2013-12-31 | $351 |
| 2013-09-30 | $330 |
| 2013-06-30 | $345 |
| 2013-03-31 | $347 |
| 2012-12-31 | $351 |
| 2012-09-30 | $361 |
| 2012-06-30 | $370 |
| 2012-03-31 | $365 |
| 2011-12-31 | $388 |
| 2011-09-30 | $364 |
| 2011-06-30 | $357 |
| 2011-03-31 | $335 |
| 2010-12-31 | $316 |
| 2010-09-30 | $242 |
| 2010-06-30 | $191 |
| 2010-05-31 | |
| 2010-03-31 | $184 |
| 2010-02-28 | $180 |
| 2009-12-31 | |
| 2009-11-30 | $169 |
| 2009-09-30 | $165 |
| 2009-08-31 | $165 |
| 2009-05-31 | |
| 2009-02-28 | $161 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.449B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |